15th INTERNATIONAL CONGRESS OF PARKINSON'S

Tuesday, June 7, 2011
3309 Teaching Course
15:00 The clinical spectrum of ICDs and dopamine
dysregulation syndrome (DDS)
Mark Stacy
Durham, NC, USA
15:40 How to detect ICDs in Parkinson’s disease
Daniel Weintraub
Philadelphia, PA, USA
16:20 How to manage ICDs in Parkinson’s disease
Andrew Evans
Parkville, Australia
At the conclusion of this session, participants should be
better able to:
1. Discuss the relationship between ICDs and dopamine
dysregulation syndrome (DDS) in Parkinson’s disease
2. Identify behaviors suggestive of ICD and DDS
3. Describe the management of ICD and DDS
Recommended Audience: Clinical Academicians; Practitioners;
Non-Physician Health Professionals; Students/Residents/Trainees
TICKET
3310 Teaching Course
From bench top to bedside: Current topics in
translation research in movement disorders
15:00 – 17:00
Location: South Building, Level 800, Room 801B
Chairs: Charles Adler
Scottsdale, AZ, USA
Keith Josephs
Rochester, NY, USA
15:00 Understanding tau-protein dysfunction and pathways
to curative
Rohan de Silva
London, United Kingdom
15:40 The anatomical source of the signs and symptoms of
Parkinson’s disease
Maria Rodriguez-Oroz
Pamplona, Spain
16:20 Current concepts of dyskinesias, and new therapeutic
strategies
M. Angela Cenci
Lund, Sweden
At the conclusion of this session, participants should be
better able to:
1. Understand the role of tau protein dysfunction in
neurodegeneration and potential treatment strategies
2. Understand biological models of dyskinesias and
insights they give to therapeutic options.
3. Discuss clinical and pathological correlations in
Parkinson’s disease through an understanding selective
regional vulnerability to Lewy body pathology
Recommended Audience: Clinical Academicians; Practitioners;
Students/Residents/Trainees
15 th INTERNATIONAL CONGRESS OF PARKINSON’S
DISEASE AND MOVEMENT DISORDERS
TICKET continued
TICKET
3403 Skills Workshop
Dystonia and spasticity: What’s the latest in
botulinum toxin therapy?
17:30 – 19:00
Location: South Building, Level 700, Room 713AB
In this interactive session, clinical vignettes and videos will be
presented to illustrate new clinical indications for botulinum toxin
therapy, effects of botulinum toxin therapy in early and late cases of
dystonia and spasticity, and use of EMG, nerve stimulation, and
ultrasound in administration of botulinum toxin therapy.
Dirk Dressler
Hannover, Germany
Raymond Rosales
Manila, Philippines
At the conclusion of this session, participants should be
better able to:
1. Understand the nature of muscle contractions in dystonia
and spasticity in relation to botulinum toxin therapy
2. Understand the similarities and differences among the
different available botulinum toxin preparations
3. Develop a framework to select for specific effects of
botulinum toxin therapy for pain, abnormal posture,
and unwanted movements in dystonia and spasticity
Recommended Audience: Clinical Academicians; Practitioners;
Students/Residents/Trainees
Supported by an unrestricted educational grant from Merz
Pharmaceuticals, LLC.
TICKET
3404 Skills Workshop
The many faces of Parkinson’s disease
17:30 – 19:00
Location: South Building, Level 800, Room 801A
In this interactive session, the speakers will review the differences in
terms of risk factors, clinical features (motor and non-motor) and
response to pharmacological therapy between the akinetic-rigid and
tremor-dominant forms of Parkinson’s disease.
Mario Zappia
Catania, Italy
Ruth Djaldetti
Petah Tikva, Israel
At the conclusion of this session, participants should be
better able to:
1. Identify the main clinical-pathological subtypes of
Parkinson’s disease
2. Interpret whether the subtypes of Parkinson’s disease
differ in risk factors and prognosis
3. Compare the response to treatment between the
clinical subtypes of Parkinson’s disease
Recommended Audience: Clinical Academicians; Practitioners;
Students/Residents/Trainees
45
Daily Schedule
Tuesday